Asynchronous Kidney Allograft Loss After Simultaneous Pancreas-Kidney Transplantation: Impact on Pancreas Allograft Outcome at a Single Center

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1773-1777

  Rangel, E B ^a   Gonzalez, A M ^a   Linhares, M M ^a   Aguiar, W F ^a   Nogueira, M ^a   Ximenes, S ^a   Sa J R ^a   Melaragno, C S ^a   Medina Pestana, J O ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ADULT; ANEMIA; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; SEPSIS; STRESS; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; BRAZIL; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67249130778     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.107     Document Type: Article

References (18)

1. Gruessner A.C., and Sutherland D.E. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 19 (2005) 433
2. Cohen D.J., St Martin L., Christensen L.L., et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 6 (2006) 1153
3. Sutherland D.E., Gruessner R.W., Dunn D.L., et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 233 (2001) 463
4. Tesi R.J., Elkhammas E.A., Henry M.L., et al. Pattern of graft loss after combined kidney-pancreas transplant. Transplant Proc 26 (1994) 425
5. Sollinger H.W., Odorico J.S., Knechtle S.J., et al. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 228 (1998) 284
6. Chinnakotla S., Taylor R.J., DeRoover A., et al. Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation. Transplant Proc 33 (2001) 1696
7. Szmidt J., Grochowiecki T., Galazka Z., et al. Influence of pancreas and kidney function on recipient outcome. Transplant Proc 38 (2006) 263
8. McLaren A.J., Jassem W., Gray D.W., et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 13 (1999) 266
9. Ojo A.O., Wolfe R.A., Held P.J., et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63 (1997) 968
10. Rangel E.B., Melaragno C.S., de Sa J.R., et al. Risk factors for the development of posttransplantation diabetes mellitus in simultaneous pancreas and kidney recipients. Transplant Proc 36 (2004) 982
11. Schiel R., Heinrich S., Steiner T., et al. Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long term prognosis. Clin Exp Nephrol 9 (2005) 164
12. Drachenberg C.B., Klassen D.K., Weir M.R., et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68 (1999) 396
13. Maes B.D., Kuypers D., Messiaen T., et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 72 (2001) 1655
14. van Hooff J.P., Christiaans M.H., and van Duijnhoven E.M. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 19 suppl 6 (2004) vi8
15. Bouchta N.B., Ghisdal L., Abramowicz D., et al. Conversion from tacrolimus to cyclosporine is associated with significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation. Transplant Proc 37 (2005) 1857
16. Teutonico A., Schena P.F., and Di Paolo S. Glucose metabolism in renal transplant patients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16 (2005) 3128
17. van Duijnhoven E.M., Christiaans M.H., Boots J.M., et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 13 (2002) 213
18. Robertson R.P. Consequences of β-cell function and reserve after long-term pancreas transplantation. Diabetes 53 (2004) 633